BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21069552)

  • 1. Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.
    Nagase S; Katabuchi H; Hiura M; Sakuragi N; Aoki Y; Kigawa J; Saito T; Hachisuga T; Ito K; Uno T; Katsumata N; Komiyama S; Susumu N; Emoto M; Kobayashi H; Metoki H; Konishi I; Ochiai K; Mikami M; Sugiyama T; Mukai M; Sagae S; Hoshiai H; Aoki D; Ohmichi M; Yoshikawa H; Iwasaka T; Udagawa Y; Yaegashi N;
    Int J Clin Oncol; 2010 Dec; 15(6):531-42. PubMed ID: 21069552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee.
    Shigeta S; Nagase S; Mikami M; Ikeda M; Shida M; Sakaguchi I; Ushioda N; Takahashi F; Yamagami W; Yaegashi N; Udagawa Y; Katabuchi H
    J Gynecol Oncol; 2017 Nov; 28(6):e76. PubMed ID: 29027394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition.
    Nagase S; Inoue Y; Umesaki N; Aoki D; Ueda M; Sakamoto H; Kobayashi S; Kitagawa R; Toita T; Nagao S; Hasegawa K; Fukasawa I; Fujiwara K; Watanabe Y; Ito K; Niikura H; Iwasaka T; Ochiai K; Katabuchi H; Kamura T; Konishi I; Sakuragi N; Tanaka T; Hirai Y; Hiramatsu Y; Mukai M; Yoshikawa H; Takano T; Yoshinaga K; Otsuki T; Sakuma M; Inaba N; Udagawa Y; Yaegashi N;
    Int J Clin Oncol; 2010 Apr; 15(2):117-24. PubMed ID: 20333431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms.
    Yamagami W; Mikami M; Nagase S; Tabata T; Kobayashi Y; Kaneuchi M; Kobayashi H; Yamada H; Hasegawa K; Fujiwara H; Katabuchi H; Aoki D
    J Gynecol Oncol; 2020 Jan; 31(1):e18. PubMed ID: 31789001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms.
    Ebina Y; Katabuchi H; Mikami M; Nagase S; Yaegashi N; Udagawa Y; Kato H; Kubushiro K; Takamatsu K; Ino K; Yoshikawa H
    Int J Clin Oncol; 2016 Jun; 21(3):419-34. PubMed ID: 27116188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
    Lee SW; Lee TS; Hong DG; No JH; Park DC; Bae JM; Seong SJ; Shin SJ; Ju W; Lee KH; Lee YK; Cho H; Lee C; Paek J; Kim HJ; Lee JW; Kim JW; Bae DS
    J Gynecol Oncol; 2017 Jan; 28(1):e12. PubMed ID: 27894165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer.
    Ebina Y; Yaegashi N; Katabuchi H; Nagase S; Udagawa Y; Hachisuga T; Saito T; Mikami M; Aoki Y; Yoshikawa H
    Int J Clin Oncol; 2015 Apr; 20(2):240-8. PubMed ID: 25800808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy of uterine clear cell carcinoma: a review.
    Xu Y; Hanna RK; Elshaikh MA
    Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer.
    Ebina Y; Mikami M; Nagase S; Tabata T; Kaneuchi M; Tashiro H; Mandai M; Enomoto T; Kobayashi Y; Katabuchi H; Yaegashi N; Udagawa Y; Aoki D
    Int J Clin Oncol; 2019 Jan; 24(1):1-19. PubMed ID: 30291468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.
    Seino M; Nagase S; Tokunaga H; Yamagami W; Kobayashi Y; Tabata T; Kaneuchi M; Hirashima Y; Niikura H; Yoshino K; Takehara K; Baba T; Katabuchi H; Mikami M
    J Gynecol Oncol; 2024 Jan; 35(1):e15. PubMed ID: 38037547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.
    Hasegawa K; Nagao S; Yasuda M; Millan D; Viswanathan AN; Glasspool RM; Devouassoux-Shisheboran M; Covens A; Lorusso D; Kurzeder C; Kim JW; Gladieff L; Bryce J; Friedlander M; Fujiwara K
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S90-5. PubMed ID: 25341588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.
    Saito T; Tabata T; Ikushima H; Yanai H; Tashiro H; Niikura H; Minaguchi T; Muramatsu T; Baba T; Yamagami W; Ariyoshi K; Ushijima K; Mikami M; Nagase S; Kaneuchi M; Yaegashi N; Udagawa Y; Katabuchi H
    Int J Clin Oncol; 2018 Apr; 23(2):201-234. PubMed ID: 29159773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine Neoplasms. Clinical Practice Guidelines in Oncology.
    Greer BE; Koh WJ; Abu-Rustum N; Bookman MA; Bristow RE; Campos SM; Cho KR; Copeland L; Crispens MA; Eifel PJ; Huh WK; Jaggernauth W; Kapp DS; Kavanagh JJ; Lurain JR; Morgan M; Morgan RJ; Powell CB; Remmenga SW; Reynolds RK; Alvarez Secord A; Small W; Teng N
    J Natl Compr Canc Netw; 2009 May; 7(5):498-531. PubMed ID: 19460278
    [No Abstract]   [Full Text] [Related]  

  • 14. National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma.
    Xiang M; English DP; Kidd EA
    Gynecol Oncol; 2019 Mar; 152(3):599-604. PubMed ID: 30551884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients.
    Eggink FA; Mom CH; Boll D; Ezendam NPM; Kruitwagen RFPM; Pijnenborg JMA; van der Aa MA; Nijman HW
    Gynecol Oncol; 2017 Aug; 146(2):380-385. PubMed ID: 28552255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma.
    Zhang M; Yang TJ; Desai NB; DeLair D; Kollmeier MA; Makker V; Leitao MM; Abu-Rustum NR; Alektiar KM
    Brachytherapy; 2019; 18(1):38-43. PubMed ID: 30316723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current clinical approach to newly diagnosed uterine cancer.
    Filippova OT; Leitao MM
    Expert Rev Anticancer Ther; 2020 Jul; 20(7):581-590. PubMed ID: 32531179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review.
    Olawaiye AB; Boruta DM
    Gynecol Oncol; 2009 May; 113(2):277-83. PubMed ID: 19251307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
    Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
    Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary management of uterine clear cell carcinoma: A Society of Gynecologic Oncology (SGO) review and recommendation.
    Olawaiye AB; Leath CA
    Gynecol Oncol; 2019 Nov; 155(2):365-373. PubMed ID: 31500893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.